| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13545* | 2021 |
| Mir-34: a new weapon against cancer? G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ... Molecular therapy Nucleic acids 3, 2014 | 601 | 2014 |
| Mitochondria as playmakers of apoptosis, autophagy and senescence M Abate, A Festa, M Falco, A Lombardi, A Luce, A Grimaldi, S Zappavigna, ... Seminars in cell & developmental biology 98, 139-153, 2020 | 492 | 2020 |
| Anti-inflammatory drugs as anticancer agents S Zappavigna, AM Cossu, A Grimaldi, M Bocchetti, GA Ferraro, ... International journal of molecular sciences 21 (7), 2605, 2020 | 364 | 2020 |
| Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview M Marra, IM Sordelli, A Lombardi, M Lamberti, L Tarantino, A Giudice, ... Journal of translational medicine 9, 1-14, 2011 | 282 | 2011 |
| Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism M Donadelli, I Dando, T Zaniboni, C Costanzo, E Dalla Pozza, MT Scupoli, ... Cell death & disease 2 (4), e152-e152, 2011 | 275 | 2011 |
| Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ... Clinical cancer research 18 (22), 6260-6270, 2012 | 267 | 2012 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 251 | 2018 |
| Familial papillary thyroid microcarcinoma: a new clinical entity G Lupoli, G Vitale, M Caraglia, MR Fittipaldi, A Abbruzzese, P Tagliaferri, ... The Lancet 353 (9153), 637-639, 1999 | 234 | 1999 |
| Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in … D Santini, B Vincenzi, S Galluzzo, F Battistoni, L Rocci, O Venditti, ... Clinical Cancer Research 13 (15), 4482-4486, 2007 | 226 | 2007 |
| Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib B Vincenzi, D Santini, A Russo, R Addeo, F Giuliani, L Montella, S Rizzo, ... The oncologist 15 (1), 85-92, 2010 | 217 | 2010 |
| miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ... Journal of cellular physiology 228 (7), 1506-1515, 2013 | 215 | 2013 |
| Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance R Addeo, M Caraglia, S Bellini, A Abbruzzese, B Vincenzi, L Montella, ... Journal of clinical oncology 28 (4), 543-548, 2010 | 210 | 2010 |
| Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, ... British journal of cancer 88 (12), 1971-1978, 2003 | 210 | 2003 |
| The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis A Lamberti, M Caraglia, O Longo, M Marra, A Abbruzzese, P Arcari Amino acids 26, 443-448, 2004 | 209 | 2004 |
| miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ... Cell death & disease 3 (11), e436-e436, 2012 | 198 | 2012 |
| A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo L Mele, F Paino, F Papaccio, T Regad, D Boocock, P Stiuso, A Lombardi, ... Cell death & disease 9 (5), 572, 2018 | 193 | 2018 |
| Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007 | 192 | 2007 |
| Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route I Panarese, G Aquino, A Ronchi, F Longo, M Montella, I Cozzolino, ... Expert review of anticancer therapy 19 (2), 105-119, 2019 | 185 | 2019 |
| Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in … E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ... Journal of cellular physiology 195 (1), 139-150, 2003 | 184 | 2003 |
Pierosandro Tagliaferriprofessore di oncologia medica Università magna graecia di CatanzaroZweryfikowany adres z unicz.it
